Patents by Inventor James MacDowell Markert

James MacDowell Markert has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Herpes simplex virus expressing foreign genes and method for treating cancers therewith
    Patent number: 8420071
    Abstract: An anti-cancer pharmaceutical composition includes a herpes simplex virus (HSV) vector into which a nucleic acid sequence encoding for an anti-cancer agent selected from interleukin-12, GM-CSF, and CD has been inserted. A method of treatment of a patient suffering from cancer includes administering to the patient the anti-tumor pharmaceutical composition including a HSV vector having a nucleic acid sequence encoding for an anti-cancer agent selected from interleukin-12, GM-CSF, and CD inserted therein.
    Type: Grant
    Filed: September 19, 2008
    Date of Patent: April 16, 2013
    Assignee: The UAB Research Foundation
    Inventors: Richard J. Whitley, James MacDowell Markert, George Yancey Gillespie, Jacqueline Nuss Parker
  • HERPES SIMPLEX VIRUS EXPRESSING FOREIGN GENES AND METHOD FOR TREATING CANCERS THEREWITH
    Publication number: 20090186003
    Abstract: An anti-cancer pharmaceutical composition includes a herpes simplex virus (HSV) vector into which a nucleic acid sequence encoding for an anti-cancer agent selected from interleukin-12, GM-CSF, and CD has been inserted. A method of treatment of a patient suffering from cancer includes administering to the patient the anti-tumor pharmaceutical composition including a HSV vector having a nucleic acid sequence encoding for an anti-cancer agent selected from interleukin-12, GM-CSF, and CD inserted therein.
    Type: Application
    Filed: September 19, 2008
    Publication date: July 23, 2009
    Inventors: Richard J. Whitley, James MacDowell Markert, George Yancey Gillespie, Jacqueline Nuess Parker
  • Herpes simplex virus expressing foreign genes and method for treating cancers therewith
    Publication number: 20040258667
    Abstract: An anti-cancer pharmaceutical composition includes a herpes simplex virus (HSV) vector into which a nucleic acid sequence encoding for an anti-cancer agent selected from interleukin-12, GM-CSF, and CD has been inserted. A method of treatment of a patient suffering from cancer includes administering to the patient the anti-tumor pharmaceutical composition including a HSV vector having a nucleic acid sequence encoding for an anti-cancer agent selected from interleukin-12, GM-CSF, and CD inserted therein.
    Type: Application
    Filed: July 8, 2004
    Publication date: December 23, 2004
    Inventors: Richard J. Whitley, James MacDowell Markert, George Yancey Gillespie, Jacqueline Ness Parker
  • Herpes simplex virus expressing foreign genes and method for treating cancers therewith
    Patent number: 6764675
    Abstract: An anti-cancer pharmaceutical composition includes a herpes simplex virus (HSV) vector into which a nucleic acid sequence encoding an anti-cancer agent selected from interleukin-12, GM-CSF, and CD has been inserted. A method of treatment of a patient suffering from cancer includes administering to the patient the anti-tumor pharmaceutical composition including an HSV vector having a nucleic acid sequence encoding an anti-cancer agent selected from interleukin-12, GM-CSF, and CD inserted therein.
    Type: Grant
    Filed: February 14, 2002
    Date of Patent: July 20, 2004
    Assignee: The UAB Research Foundation
    Inventors: Richard J. Whitley, James MacDowell Markert, George Yancey Gillespie, Jacqueline Ness Parker